Aroa Biosurgery Limited (ASX:ARX)

Total Valuation

Aroa Biosurgery has a market cap or net worth of AUD 220.82 million. The enterprise value is 206.52 million.

Market Cap	220.82M
Enterprise Value	206.52M

Important Dates

The next estimated earnings date is Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Aroa Biosurgery has 345.03 million shares outstanding. The number of shares has increased by 0.31% in one year.

Current Share Class	345.03M
Shares Outstanding	345.03M
Shares Change (YoY)	+0.31%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	25.04%
Owned by Institutions (%)	30.85%
Float	258.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	72.37
PS Ratio	2.87
PB Ratio	2.61
P/TBV Ratio	3.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 167.73, with an EV/FCF ratio of -46.62.

EV / Earnings	-59.61
EV / Sales	2.68
EV / EBITDA	167.73
EV / EBIT	n/a
EV / FCF	-46.62

Financial Position

The company has a current ratio of 6.62, with a Debt / Equity ratio of 0.07.

Current Ratio	6.62
Quick Ratio	5.58
Debt / Equity	0.07
Debt / EBITDA	4.74
Debt / FCF	-1.32
Interest Coverage	-6.13

Financial Efficiency

Return on equity (ROE) is -4.06% and return on invested capital (ROIC) is -1.81%.

Return on Equity (ROE)	-4.06%
Return on Assets (ROA)	-1.66%
Return on Invested Capital (ROIC)	-1.81%
Return on Capital Employed (ROCE)	-2.96%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.77
Inventory Turnover	1.48

Taxes

In the past 12 months, Aroa Biosurgery has paid 511,598 in taxes.

Income Tax	511,598
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.59% in the last 52 weeks. The beta is 0.54, so Aroa Biosurgery's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+1.59%
50-Day Moving Average	0.55
200-Day Moving Average	0.56
Relative Strength Index (RSI)	65.31
Average Volume (20 Days)	141,009

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aroa Biosurgery had revenue of AUD 76.96 million and -3.46 million in losses. Loss per share was -0.01.

Revenue	76.96M
Gross Profit	65.98M
Operating Income	-2.65M
Pretax Income	-2.95M
Net Income	-3.46M
EBITDA	231,718
EBIT	-2.65M
Loss Per Share	-0.01

Balance Sheet

The company has 20.13 million in cash and 5.83 million in debt, giving a net cash position of 14.30 million or 0.04 per share.

Cash & Cash Equivalents	20.13M
Total Debt	5.83M
Net Cash	14.30M
Net Cash Per Share	0.04
Equity (Book Value)	84.59M
Book Value Per Share	0.25
Working Capital	52.59M

Cash Flow

In the last 12 months, operating cash flow was -2.33 million and capital expenditures -2.10 million, giving a free cash flow of -4.43 million.

Operating Cash Flow	-2.33M
Capital Expenditures	-2.10M
Free Cash Flow	-4.43M
FCF Per Share	-0.01

Margins

Gross margin is 85.73%, with operating and profit margins of -3.45% and -4.50%.

Gross Margin	85.73%
Operating Margin	-3.45%
Pretax Margin	-3.84%
Profit Margin	-4.50%
EBITDA Margin	0.30%
EBIT Margin	-3.45%
FCF Margin	n/a

Dividends & Yields

Aroa Biosurgery does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.31%
Shareholder Yield	n/a
Earnings Yield	-1.57%
FCF Yield	-2.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aroa Biosurgery has an Altman Z-Score of 8.87 and a Piotroski F-Score of 3.

Altman Z-Score	8.87
Piotroski F-Score	3